2026 NPPES data Medical Oncology Physician NPI 1801828330 M.D.
Verify on CMS →

RENU LAMBA, M.D.

Medical Oncology Physician in BAYONNE, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 57 beneficiaries · Medical Oncology Physician avg: 689
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$33.83
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RENU LAMBA, M.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 1,147 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
1K
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RENU LAMBA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

RENU LAMBA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RENU LAMBA, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/07/2006

NPI 1801828330

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

1,147 66% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Medical Oncology Physician compares to other specialties among New Jersey providers

New Jersey providers

Medical Oncology Physician share within New Jersey

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within New Jersey

Medicare quality performance — MIPS

RENU LAMBA, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Medical Oncology Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RENU LAMBA, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 473 BROADWAY, BAYONNE, NJ, 07002, with a listed phone of (201) 285-5972. NPI 1801828330 was issued on 07/07/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LAMBA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,147 prescription claims written by this provider, covering 57 Medicare beneficiaries and totaling roughly $903K in drug spend, with an opioid prescribing rate of 2.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

473 BROADWAY
BAYONNE, NJ 07002

Provider Details

NPI 1801828330
Specialty Medical Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 07/07/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Quality
95
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RENU LAMBA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$34

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,147
Total Claims
$903K
Total Drug Cost
57
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,405
Total Day Supply
38,361
Generic Drug Cost
$164K
Opioid Claims
28 (2.4% rate)
Antibiotic Claims
69

Patient Demographics

Average Patient Age
73.8 years
Avg HCC Risk Score
2.19
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RENU LAMBA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Famotidine
84
Warfarin Sodium
60
Ondansetron Hcl
53
Amlodipine Besylate
45
Nystatin
39
Valacyclovir
Valacyclovir Hcl
39
Ropinirole Hcl
38
Levothyroxine Sodium
37
Procrit
Epoetin Alfa
37
Granix
Tbo-Filgrastim
29

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How RENU LAMBA, M.D. fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

RENU LAMBA, M.D.'s 1,147 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as LAMBA.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RENU LAMBA, M.D.'s specialty?
RENU LAMBA, M.D. specializes in Medical Oncology Physician and practices in BAYONNE, New Jersey. Credentials: M.D..
How much does RENU LAMBA, M.D. prescribe under Medicare Part D?
In 2023, RENU LAMBA, M.D. wrote 1,147 Medicare Part D claims totaling $903K in drug costs for 57 beneficiaries.
What is RENU LAMBA, M.D.'s Medicare quality score?
RENU LAMBA, M.D. has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RENU LAMBA, M.D. located?
RENU LAMBA, M.D. is located at 473 BROADWAY, BAYONNE, NJ, 07002. Phone: (201) 285-5972.
What is RENU LAMBA, M.D.'s NPI number?
RENU LAMBA, M.D.'s National Provider Identifier (NPI) is 1801828330, issued on 07/07/2006.
Does RENU LAMBA, M.D. prescribe opioids?
Yes, RENU LAMBA, M.D. had 28 opioid claims in 2023 with an opioid prescribing rate of 2.4%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does RENU LAMBA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RENU LAMBA, M.D.'s most frequently prescribed drugs include Famotidine, Warfarin Sodium, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RENU LAMBA, M.D. accept Medicare?
RENU LAMBA, M.D. appears in CMS Medicare data with 1,147 Part D claims and 57 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RENU LAMBA, M.D.'s credentials?
RENU LAMBA, M.D.'s NPI is 1801828330 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology